Showing all 11 results
-
Buy Lynparza (Olaparib) Online For Sale
$5,053.65DISEASE INDICATIONS: Breast Cancer, Gynaecological Cancer
MANUFACTURER: AstraZeneca AB
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Medsafe (NZ)
Lynparza is a medication that inhibits PARP enzymes, which repair DNA, to treat ovarian, fallopian tube, or primary peritoneal cancer in adults who have undergone more than three chemotherapy treatments, and it promotes cancer cell death.
-
Buy Ninlaro (ixazomib) Online For Sale
$5,713.05DISEASE INDICATIONS: Multiple Myeloma
MANUFACTURER: Takeda Pharma A/S
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Pharmaceuticals and Medical Devices Agency (PMDA)
Therapeutic Goods Administration (TGA)
Ninlaro (ixazomib) is an oral medication used to treat multiple myeloma in combination with other drugs by blocking proteasome activities to promote cancer cell death.
-
Buy Odomzo (sonidegib) Online For Sale
$5,229.00DISEASE INDICATIONS: Skin Cancer
MANUFACTURER: Sun Pharmaceutical Industries Europe B.V.
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Therapeutic Goods Administration (TGA)
Odomzo (sonidegib) is a medication used to treat basal cell carcinoma (BCC) in patients who cannot undergo surgery or radiation, or whose disease has recurred following such treatment.
-
Buy Onivyde (irinotecan hydrochloride trihydrate) Online For Sale
$990.15DISEASE INDICATIONS: Pancreatic Cancer
MANUFACTURER: Baxalta Innovations GmbH
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Medsafe (NZ)
Onivyde (irinotecan hydrochloride trihydrate) is an injectable medication used to treat metastatic adenocarcinoma of the pancreas. It works by inhibiting topoisomerase I, an enzyme necessary for DNA replication in cancer cells.
-
Buy Perjeta (Pertuzumab) Online For Sale
$2,441.25DISEASE INDICATIONS: Breast Cancer
MANUFACTURER: Roche Registration Limited
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Medsafe (NZ)
Perjeta (Pertuzumab) is a monoclonal antibody medication used for treating specific types of breast cancer that overexpress the HER2 protein. It works by binding to the HER2 protein, preventing cancer cell growth and promoting cell death.
-
Buy Portrazza (necitumumab) Online For Sale
$7,384.65DISEASE INDICATIONS: Lung Cancer
MANUFACTURER: Eli Lilly Nederland B.V.
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Portrazza is a monoclonal antibody used with gemcitabine and cisplatin to treat metastatic squamous non-small cell lung cancer, indicating for use only for patients with squamous non-small cell lung cancer. It targets the EGFR protein and prevents cancer cells’ growth and promotes cell death.
-
Buy Rubraca (rucaparib) Online For Sale
From $1,614.90DISEASE INDICATIONS: Gynaecological Cancer
MANUFACTURER: Clovis Oncology, Inc.
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Rubraca (rucaparib) is an orally administered medication used for the treatment of advanced ovarian cancer and prostate cancer.
-
Buy Rydapt (midostaurin) Online For Sale
$14,017.50DISEASE INDICATIONS: Leukemia
MANUFACTURER: Novartis Europharm Limited
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Medsafe (NZ)
Rydapt, also known as midostaurin, is used to treat patients with newly diagnosed acute myeloid leukemia (AML), aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).
-
Buy Tagrisso (Osimertinib) Online For Sale
$5,460.00DISEASE INDICATIONS: Lung Cancer
MANUFACTURER: AstraZeneca AB
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Medsafe (NZ)
Tagrisso is a medication used to treat non-small cell lung cancer with EGFR T790M mutation. It inhibits the activity of the EGFR protein, leading to cancer cell death.
-
Buy Tecentriq (Atezolizumab) Online For Sale
$5,983.95DISEASE INDICATIONS: Urothelial Carcinoma, Breast Cancer, Lung Cancer
MANUFACTURER: Roche Registration Limited
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Pharmaceuticals and Medical Devices Agency (PMDA)
Therapeutic Goods Administration (TGA)
Medsafe (NZ)
Tecentriq (Atezolizumab) is an immunotherapy drug used to treat advanced non-small cell lung cancer and urothelial carcinoma (bladder cancer). By blocking protein PD-L1, it helps the immune system attack and destroy cancer cells.
-
Buy Zejula (niraparib) Online For Sale
From $4,789.05DISEASE INDICATIONS: Gynaecological Cancer
MANUFACTURER: Tesaro UK Limited
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Zejula is an oral PARP inhibitor used for the treatment of recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancers in adult patients. Its mechanism of action blocks the PARP enzyme, preventing cancer cells from repairing damaged DNA causing their death.